| 摘要 |
<p>The use of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3-yl) acetonitrile or a pharmaceutically acceptable salt thereof for treatment of psychosis or other neuropsychiatric symptoms in patients with Alzheimer's Disease with severe behavioural disturbance.</p> |
